This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The FDA approved nitisinone (Harliku) for the reduction of urine homogentisic acid (HGA) in patients with alkaptonuria (AKU). The FDA approved nitisinone (Harliku) for the reduction of urine homogentisic acid (HGA) in patients with alkaptonuria (AKU). The medication is expected to launch in July 2025. REFERENCES 1.
READ MORE: Q&A: Retail, IndependentPharmacies Continue to Call for Improved Reimbursement Practices Don’t get left behind: Sign up today for our free Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips delivered straight to your inbox.
1 "Lilly was the first company to offer a self-pay solution for an FDA-approved obesity medication, and we continue to work to expand coverage for Zepbound. mg and 15 mg vials of tirzepatide starting July 7, with shipments beginning in early August.
The FDA approved telmisartan, amlodipine and indapamide (Widaplik) for the treatment of hypertension in adult patients, George Medicines said in a release. The FDA approved telmisartan, amlodipine and indapamide (Widaplik) for the treatment of hypertension in adult patients, George Medicines said in a release. References 1.
The Potential Impact Pharmaceutical Tariffs May Have on Pharmacies Brian Nowosielski ; Marta Wosinska, PhD ; Joey Mattingly, PharmD, MBA, PhD June 12th 2025 Podcast Marta Wosinska, PhD, and Joey Mattingly, PharmD, MBA, PhD, joined Drug Topics to help us understand how pharmaceutical tariffs could potentially impact the pharmacy industry.
link] Recent Videos Related Content CDC Report Finds No Connection Between Thimerosal and Autism Ashley Gallagher June 25th 2025 Article Thimerosal is a mercury-containing compound that has been widely used as a preservative in some biological and drug products since the 1930s.
CDC Report Finds No Connection Between Thimerosal and Autism Ashley Gallagher June 25th 2025 Article Thimerosal is a mercury-containing compound that has been widely used as a preservative in some biological and drug products since the 1930s.
News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy (..)
Recent Videos Related Content FDA to Evaluate Merck’s Doravirine, Islatravir Regimen for HIV-1 Killian Meara July 10th 2025 Article The FDA set a Prescription Drug User Fee Act (PDUFA) date of April 28, 2026. Subscribe Now!
The Ongoing Challenges Causing Need for Reform in Retail Pharmacy Brian Nowosielski ; Rick Gates July 3rd 2025 Podcast As state-level PBM reform heats up amid dire situations for many retail pharmacies, Walgreens Chief Pharmacy Officer Rick Gates joins Drug Topics to discuss ongoing industry challenges.
link] Recent Videos Related Content Eli Lilly Adds Highest Doses of Zepbound to Online Pharmacy Platform Ashley Gallagher June 16th 2025 Article Providers can prescribe the 12.5 Related Content Eli Lilly Adds Highest Doses of Zepbound to Online Pharmacy Platform Ashley Gallagher June 16th 2025 Article Providers can prescribe the 12.5
3,4 Since then, several other formulations have received FDA approval, leading to research developments of multiple GLP-1s for treating people with overweight or obesity. image credit: photoopus / stock.adobe.com The first GLP-1RA approved for use in the US was exenatide (Byetta) in 2005 for patients with type 2 diabetes (T2D).
Q&A: How Technician Fatigue Threatens Patient Safety, Care Killian Meara ; Taylor Watterson, PharmD, PhD July 1st 2025 Article Taylor Watterson, PharmD, PhD, discusses how pharmacy technician burnout can impact pharmacy operations.
Recent Videos Related Content Q&A: Pharmacies Grapple With Patient Influx Amid Rite Aid Closures Killian Meara ; Rob Frankil, RPh July 1st 2025 Article Rob Frankil, RPh, discusses how independentpharmacies in Pennsylvania are dealing with the impact of Rite Aid stores closing.
Recent Videos Related Content Healthy Margins: How IndependentPharmacies Can Strengthen Their Bottom Line Chris Cella, R.Ph., Related Content Healthy Margins: How IndependentPharmacies Can Strengthen Their Bottom Line Chris Cella, R.Ph., Subscribe Now!
Related Content Register Today: June 2025 Total Pharmacy Solutions Summit Brian Nowosielski June 2nd 2025 Article The event will focus on revenue stream diversification, providing independentpharmacies with seeds of innovation and practical tools to cultivate new avenues for growth in pharmacy.
Not only is it important for pharmacies and their employees to have protocols for natural disasters, but pharmacies should also educate their patients on properly storing and managing their medications during a state of emergency. Taking precautions for storing medications and supplies is key to being prepared,” the FDA wrote.
link] Recent Videos Related Content Pharmacist Outreach Reduces Therapeutic Inertia in T2D | ADA 2025 Killian Meara June 23rd 2025 Article Data presented at ADA’s 85th Scientific Sessions showed patients who received physician education with clinical pharmacist outreach had significantly better A1c levels at 6 months compared to usual care.
Recent Videos Related Content Diabetes Risk Reduction Practices Low for Women With Gestational Diabetes Ashley Gallagher June 13th 2025 Article For women in rural populations, access to education and care is limited, causing disparities in diabetes care.
The community pharmacy sector is facing unprecedented challenges, with shrinking margins and evolving health care dynamics putting increasing pressure on independentpharmacies.
Recent Videos Related Content Register Today: June 2025 Total Pharmacy Solutions Summit Brian Nowosielski June 2nd 2025 Article The event will focus on revenue stream diversification, providing independentpharmacies with seeds of innovation and practical tools to cultivate new avenues for growth in pharmacy.
News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy (..)
2 This potential to boost profitability is critical for independentpharmacies navigating tight operating budgets. 3 These value-conscious, quality-driven customers provide independentpharmacies with an opportunity to strengthen loyalty and increase basket size.
Knockel: I'm encouraging patients to talk to trusted health care professionals and to not get their advice from social media or the internet or other strangers, focusing on the fact that vaccines have been studied before, during, and after FDA approval.
News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy (..)
News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy (..)
News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy (..)
link] Recent Videos Related Content FDA Grants Expanded Interchangeability Designation to Yuflyma Ashley Gallagher May 23rd 2025 Article Adalimumab-aaty (Yuflyma) prefilled syringes and autoinjectors are now fully interchangeable with the reference product adalimumab (Humira) across marketed dosage forms and strengths.
News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy (..)
News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy (..)
News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy (..)
News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy (..)
FDA Approves Roflumilast Foam For Plaque Psoriasis of Scalp, Body Ashley Gallagher May 22nd 2025 Article The supplemental new drug application for roflumilast (Zoryve) is approved for adult and pediatric patients 12 years and older.
News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy (..)
News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy (..)
News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy (..)
News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy (..)
News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy (..)
Diabetes Care. 2024;47(3):331-343. doi:10.2337/dci23-0037 Recent Videos Related Content Semaglutide Lowers Risk of Kidney Disease Events in Patients With Type 2 Diabetes, CKD Killian Meara June 17th 2025 Article Real-world effectiveness data showed semaglutide reduced the risk of major kidney disease events by 26%.
Should You Keep Compounding GLP1s (Tirzepatide or Semaglutide) After the FDA Deadline? Howdy pharmacy peeps… Lets have a real talk about compounding GLP1s. These compounds have been huge revenue drivers and powerful tools for helping patients lose weight and improve metabolic health. Here’s My Take.
Rite Aid, which was once the third largest pharmacy chain in the United States, announced in May that it filed its second chapter 11 bankruptcy in under 2 years. Drug Topics : How has the closure of Rite Aid stores impacted independentpharmacies in Pennsylvania? Rob Frankil, RPh : I'm seeing a mixed bag.
link] Recent Videos Related Content Steatosis Liver Disease Shows Increased Risk of Diabetes for Patients With Atrial Fibrillation Ashley Gallagher June 12th 2025 Article Investigators find that the risk for new-onset diabetes is especially prominent for patients aged 20 to 29 years.
link] Recent Videos Related Content FDA Approves Dupilumab for Treatment of Bullous Pemphigoid Ashley Gallagher June 20th 2025 Article Bullous pemphigoid is a rare skin condition that causes large blisters filled with fluids that typically occur near skin creases, such as the upper thighs and armpits. Jefferson Health. Accessed June 20, 2025.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content